OpenAlex topic

Multiple Sclerosis Research Studies

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 3,237 works 222 author topics

Works

3,237 works

Multipl Sklerozda İmmünsupresif Tedaviler 2026
Multipl skleroz (MS), inflamasyon, demiyelinizasyon ve nörodejenerasyon ile seyreden kronik otoimmün bir santral sinir sistemi hastalığıdır. Hastalık modifiye edici tedavilere rağmen bazı hastalarda yüksek hastalık aktivitesi ve progresyon devam edebilmektedir. Bu durumlarda immünsupresif tedaviler, bağışıklık aracılı…
Association between breastfeeding duration and disability in multiple sclerosis 2026
No abstract yet.
Differential safety profiles of disease-modifying therapies in MS: Age- and sex-based analysis from a real-world cohort 2026
No abstract yet.
Defining the Predictors of Fatigue in People with Multiple Sclerosis 2026
Objective: This study aimed to define the predictors of fatigue in people with multiple sclerosis (MS, pwMS) by evaluating clinical and demographic factors, including disability level, physical performance, sleepiness, and depression. Material and Methods: A total of 747 pwMS were included in this cross-sectional stud…
Impact of pain subtypes on disability and quality of life in multiple sclerosis: Neuropathic pain demonstrates the strongest association 2026
No abstract yet.
THE EFFECT OF BALANCE TRAINING PERFORMED WITH STROBOSCOPIC GLASSES ON REACTION TIME IN INDIVIDUALS WITH MULTIPLE SCLEROSIS: A CASE SERIES 2026
No abstract yet.
THE EFFECT OF BALANCE TRAINING PERFORMED WITH STROBOSCOPIC GLASSES ON REACTION TIME IN INDIVIDUALS WITH MULTIPLE SCLEROSIS: A CASE SERIES 2026
No abstract yet.
Severity Variant rs10191329 has no Effect on Prognostic Factors, Serum GFAP Levels and Cognitive Impairment in Turkish Patients With Multiple Sclerosis (P5-18.009) 2026
Our case-control study investigated the effect of carrying the rs10191329*A allele on prognostic factors, serum GFAP (sGFAP) levels and cognitive decline in Turkish multiple sclerosis (MS) patients.
Subcortical Gray Matter Atrophy in Multiple Sclerosis: A Comparison Between RRMS and PMS Subtypes (P8-19.008) 2026
This study aimed to compare deep gray matter (GM) atrophy patterns and their functional correlates between relapsing–remitting MS (RRMS) and progressive MS (PMS) patients.
Beyin Damar Hastalıkları ve Glial Tümörler 2026
No abstract yet.
Agomelatine restores apoptotic and glial homeostasis in methotrexate-induced cortical neurotoxicity 2026
No abstract yet.
Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 2026
No abstract yet.

Academicians

222 academicians